AAAAAA

   
Results: 1-8 |
Results: 8

Authors: von Mehren, M Arlen, P Gulley, J Rogatko, A Cooper, HS Meropol, NJ Alpaugh, RK Davey, M McLaughlin, S Beard, MT Tsang, KY Schlom, J Weiner, LM
Citation: M. Von Mehren et al., The influence of granulocyte macrophage colony-stimulating factor and prior chemotherapy on the immunological response to a vaccine (ALVAC-CEA B7.1) in patients with metastatic carcinoma, CLIN CANC R, 7(5), 2001, pp. 1181-1191

Authors: Figg, WD Arlen, P Gulley, J Fernandez, P Noone, M Fedenko, K Hamilton, M Parker, C Kruger, EA Pluda, J Dahut, WL
Citation: Wd. Figg et al., A randomized phase II trial of docetaxel (taxotere) plus thalidomide in androgen-independent prostate cancer, SEMIN ONCOL, 28(4), 2001, pp. 62-66

Authors: Zhu, MZ Terasawa, H Gulley, J Panicali, D Arlen, P Schlom, J Tsang, KY
Citation: Mz. Zhu et al., Enhanced activation of human T cells via avipox vector-mediated hyperexpression of a triad of costimulatory molecules in human dendritic cells, CANCER RES, 61(9), 2001, pp. 3725-3734

Authors: Tsang, KY Zhu, MZ Even, J Gulley, J Arlen, P Schlom, J
Citation: Ky. Tsang et al., The infection of human dendritic cells with recombinant avipox vectors expressing a costimulatory molecule transgene (CD80) to enhance the activationof antigen-specific cytolytic T cells, CANCER RES, 61(20), 2001, pp. 7568-7576

Authors: von Mehren, M Arlen, P Tsang, KY Rogatko, A Meropol, N Cooper, HS Davey, M McLaughlin, S Schlom, J Weiner, LM
Citation: M. Von Mehren et al., Pilot study of a dual gene recombinant avipox vaccine containing both carcinoembryonic antigen (CEA) and B7.1 transgenes in patients with recurrent CEA-expressing adenocarcinomas, CLIN CANC R, 6(6), 2000, pp. 2219-2228

Authors: Eder, JP Kantoff, PW Roper, K Xu, GX Bubley, GJ Boyden, J Gritz, L Mazzara, G Oh, WK Arlen, P Tsang, KY Panicali, D Schlom, J Kufe, DW
Citation: Jp. Eder et al., A phase I trial of a recombinant vaccinia virus expressing prostate-specific antigen in advanced prostate cancer, CLIN CANC R, 6(5), 2000, pp. 1632-1638

Authors: Marshall, JL Hoyer, RJ Toomey, MA Faraguna, K Chang, P Richmond, E Pedicano, JE Gehan, E Peck, RA Arlen, P Tsang, KY Schlom, J
Citation: Jl. Marshall et al., Phase I study in advanced cancer patients of a diversified prime-and-boostvaccination protocol using recombinant vaccinia virus and recombinant nonreplicating avipox virus to elicit anti-carcinoembryonic antigen immune responses, J CL ONCOL, 18(23), 2000, pp. 3964-3973

Authors: Arlen, P Tsang, KY Marshall, JL Chen, A Steinberg, SM Poole, D Hand, PH Schlom, J Hamilton, JM
Citation: P. Arlen et al., The use of a rapid ELISPOT assay to analyze peptide-specific immune responses in carcinoma patients to peptide vs. recombinant poxvirus vaccines, CANCER IMMU, 49(10), 2000, pp. 517-529
Risultati: 1-8 |